Australia's international outlook, strong science base, multi-ethnic English-speaking population and high educational and regulatory standards make it…

In a recent article for PharmaBoardroom, Objective Capital's David Crean took a look at the state of US innovation today and its long term…

A selection of data on the Nordic pharma markets (Denmark, Finland, Iceland, Norway, and Sweden), including market value, R&D spend, production,…

A full list of EMA ATMP approvals. Made with Visme Infographic Maker  

A full list of the cell and gene therapy products approved by the US FDA. Made with Visme Infographic Maker  

A full list of the regenerative medicine products that have been approved by the PMDA, Japan's drug regulatory body. Made with Visme…

Annual numbers of new molecular entities (NMEs) and biologics license applications (BLAs) approved by the FDA's Center for Drug Evaluation and…

An overview of the types of new medicines recommended for approval by the European Medicines Agency (EMA) in 2019. Made with Visme Infographic…

 A new report from the UK BioIndustry Association (BIA) asserts that the UK biotech industry is booming, despite Brexit uncertainties. Financing…

A snapshot of the latest data on the French pharmaceutical industry from industry association LEEM, including market revenues, R&D investments,…

Czech Republic's overall pharma market value increased 5 per cent in 2019, while its units produced decreased by 1 per cent. Made…

Poland is by far the largest pharma market in the Central and Eastern Europe (CEE) region, with a total value of EUR 6.352 billion for 2017. The Czech…